Boyden is pleased to share the appointment news of Dr. Keith Stewart, a recruitment led by Pamela Colquhoun
Toronto, ON - February 18, 2020
Announcement by Kevin Smith, President & CEO, UHN and Brian Hodges, EVP Education & Chief Medical Officer and Garth Matheson, Interim President & CEO, Ontario Health (Cancer Care Ontario), UHN:
We are very pleased to announce the appointment of Dr. Keith Stewart as Vice-President, Cancer, and Director of the Princess Margaret Cancer Program, University Health Network, and Regional Vice-President, Toronto Central South Regional Cancer Program, Ontario Health (Cancer Care Ontario), effective June 1, 2020.
Dr. Keith Stewart currently serves as the Carlson and Nelson Endowed Director of the Mayo Clinic Center for Individualized Medicine and is recognized as the Vasek and Anna Maria Polak Professor of Cancer Research. Dr. Stewart’s responsibilities at the Mayo Clinic include the application of genomics to human health across the spectrum of discovery, translation and application to clinical practice.
Dr. Stewart received his medical degree at Aberdeen University Medical School and trained in internal medicine and hematology in Glasgow, Kingston, Toronto and Boston. He was Active Staff at the Toronto General and Princess Margaret hospitals from 1992 to 2005, and held the J. Gerald Scott/David G. Whitmore Chair in Hematology and Gene Therapy at the University of Toronto. In 2002, Dr. Stewart completed a Master’s in Business Administration at the Ivey Business School, University of Western Ontario.
Dr. Stewart has served in several leadership roles across both research and clinical practice in Toronto and at the Mayo Clinic, including as Director of Research at Toronto General Hospital and as Founding Director of the McLaughlin Centre for Molecular Medicine at the University of Toronto. At the Mayo Clinic, he was the Dean for Research in Arizona, and a member of the Arizona Executive Operations Team and Clinical Practice Committees. He has served on multiple boards for both non-profit and commercial organizations, including currently as a Non-Executive Board member with Genomics England and a member of the Advisory Boards of Helix Inc., Veritas Genetics, Inc., Tempus Inc., and the Multiple Myeloma Research Foundation Investment Committee.
Dr. Stewart has more than 25 years of sustained national funding for a laboratory research program in genomics and biology of multiple myeloma and has led numerous clinical trials of new drugs for this blood cancer. He has held editorial responsibilities for several prominent publications and has authored more than 350 peer reviewed research papers.
Please join us in congratulating and welcoming Dr. Stewart to UHN and Cancer Care Ontario.
Dr. Gospodarowicz and Marnie Escaf will continue as Program Medical Director/RVP and Senior Vice President respectively until Dr. Stewart’s arrival on June 1, 2020. We will be communicating further information about an important leadership role for Marnie Escaf in the near future.
Kevin Smith
President & CEO
University Health Network
Brian Hodges
EVP Education & Chief Medical Officer
Garth Matheson
Interim President & CEO
Ontario Health (Cancer Care Ontario)
University Health Network
Original Source: Princess Margaret CF Twitter
